Evidence map›Paper›PMID 42525595›Full record

ArticlePain research & management2026

Pain Medication Use and Perceived Effectiveness in People With Multiple Sclerosis: A Mixed-Methods Study.

Mohammed Suleiman Obsa, Alice Saul, Kristen Lefever, A Julie Campbell, L Laura Laslett, Baye Dagnew, V Bruce Taylor, Ingrid van der Mei

Abstract read
In one paragraph

Article in Pain research & management, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Mohammed Suleiman ObsaMenzies Institute for Medical Research, University of Tasmania, Hobart, Tasmania, Australia, utas.edu.au.ORCID https://orcid.org/0000-0002-6579-1136
Alice SaulMenzies Institute for Medical Research, University of Tasmania, Hobart, Tasmania, Australia, utas.edu.au.ORCID https://orcid.org/0000-0003-0942-0469
Kristen LefeverSchool of Medicine, University of Queensland, Brisbane, Queensland, Australia, health.qld.gov.au.ORCID https://orcid.org/0000-0002-5990-3904
A Julie CampbellMenzies Institute for Medical Research, University of Tasmania, Hobart, Tasmania, Australia, utas.edu.au.ORCID https://orcid.org/0000-0002-1820-6758
L Laura LaslettMenzies Institute for Medical Research, University of Tasmania, Hobart, Tasmania, Australia, utas.edu.au.ORCID https://orcid.org/0000-0002-4336-0095
Baye DagnewMenzies Institute for Medical Research, University of Tasmania, Hobart, Tasmania, Australia, utas.edu.au.ORCID https://orcid.org/0000-0002-2397-5930
V Bruce TaylorMenzies Institute for Medical Research, University of Tasmania, Hobart, Tasmania, Australia, utas.edu.au.ORCID https://orcid.org/0000-0003-2807-0070
Ingrid van der MeiMenzies Institute for Medical Research, University of Tasmania, Hobart, Tasmania, Australia, utas.edu.au.ORCID https://orcid.org/0000-0001-9009-7472

Funding

Council of Australasian University LibrariansMenzies Institute for Medical ResearchMS AustraliaNational Health and Medical Research CouncilTasmania Graduate Research ScholarshipUniversity of Tasmania
6 · The paper itself

Abstract

backgroundIndividuals with multiple sclerosis (MS) often use multiple medications, but evidence comparing their effectiveness is scarce. This study aims to (a) describe pain medication use and perceived effectiveness, (b) identify factors associated with the total number of pain medications, (c) explore the reasons for stopping and (d) use qualitative data to explore the lived experience of PwMS in relation to pain medication effectiveness and reasons for stopping.

methodsParticipants from the Australian MS Longitudinal Study completed a pain survey in 2021 (n = 1691); 26 participants self-nominated to participate in focus groups. Participants with regular pain were asked which pain medications they used, to what extent the medications reduced pain, which medications they stopped using and the reasons for stopping. Quantitative data were analysed using descriptive statistics; negative binomial regression was used to determine factors associated with the total number of medications. Qualitative data were analysed using thematic analysis.

resultsAmong 899 participants with regular pain, 87.3% were using pain medication. In terms of perceived effectiveness, 62.3% of all reported medications resulted in 'much improvement', 'very much improvement' or 'complete pain relief'. The medications commonly reported to be effective were opioid-containing medications, cannabinoids, antimigraine medications, a combination of paracetamol and nonsteroidal anti-inflammatory drug (NSAID) products and sedatives. Having more pain types, greater pain severity, being female and greater disability (all p < 0.05) were associated with taking a higher number of medications. Common reasons for stopping a medication were side effects and ineffectiveness. Qualitative data supported the quantitative findings.

conclusionsMost people with pain used medications, and the effectiveness was acceptable for the majority of people. Despite that, stopping medications until the right ones were found was common, often due to side effects and ineffectiveness. This suggests that, with adjustments to treatment plans, effective pain control is achievable for most PwMS with pain.

Indexed as

AnalgesicsMultiple SclerosisPainAdultAustraliaFemaleHumansLongitudinal StudiesMaleMiddle AgedPain ManagementPain MeasurementSurveys and QuestionnairesTreatment OutcomeAnalgesicsepidemiologymixed methodmultiple sclerosispainpain medications

Identifiers

PMID42525595
PMCPMC13419084

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.